Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Condition(s):Metastatic Pancreatic AdenocarcinomaLast Updated:October 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Pancreatic AdenocarcinomaLast Updated:October 13, 2023Recruiting
Condition(s):Ectropion; Skin NeoplasmsLast Updated:March 9, 2020Completed
Condition(s):Carcinoma, Squamous CellLast Updated:November 15, 2023Recruiting
Condition(s):Hepatocellular Carcinoma; RecurrenceLast Updated:October 21, 2016Unknown status
Condition(s):TDM of 5-FU; Pharmacokinetic Observational StudyLast Updated:December 30, 2022Recruiting
Condition(s):Actinic KeratosisLast Updated:July 17, 2019Completed
Condition(s):Plantar WartLast Updated:September 28, 2021Unknown status
Condition(s):Brow Ptosis; Facial ScarringLast Updated:July 26, 2018Unknown status
Condition(s):Advanced Biliary Tract CancerLast Updated:December 22, 2023Recruiting
Condition(s):Gastric Cancer; Bone Marrow Metastasis; Disseminated Intravascular CoagulationLast Updated:March 25, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.